Vivus Inc. to Present Study Results of Topamax Links to Birth Defects By Month’s End

Vivus Inc. announced in July that it will be presenting data from a study looking at the linkages between Topiramate (Topamax) and birth defects on August 31, 2011. Vivus officials...